AstraZeneca US
EXCLUSIVE AstraZeneca exploring options for COVID-19 vaccine business - executive | Reuters
AstraZeneca unveils successes in treatment of lung cancer
AstraZeneca wins EU backing for heart drug, but suffers lung cancer setback | Reuters
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
Annual Reports
U.S. FDA approves AstraZeneca's lung cancer drugs | Reuters
AstraZeneca makes big push into weight-loss market with obesity pill deal | AstraZeneca | The Guardian
AstraZeneca - Vivli
Externally Sponsored Scientific Research - AstraZeneca
Annual report 2022
AstraZeneca to pay $425 million to settle lawsuits over heartburn drugs | The Hill
FDA pulls authorization for AstraZeneca's Covid antibody drug Evusheld
Ethics and transparency - Our Company - AstraZeneca
Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca - The New York Times
Partnering
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework | Nature Reviews Drug Discovery
No plans for UK to order more supplies of AstraZeneca Covid vaccine | Coronavirus | The Guardian
Coronavirus (COVID-19) information & research hub | AstraZeneca
Annual Reports
AstraZeneca - Research-Based BioPharmaceutical Company
About Our Company - AstraZeneca
Ethics and transparency - Our Company - AstraZeneca
